OverDrive would like to use cookies to store information on your computer to improve your user experience at our Website. One of the cookies we use is critical for certain aspects of the site to operate and has already been set. You may delete and block all cookies from this site, but this could affect certain features or services of the site. To find out more about the cookies we use and how to delete them, click here to see our Privacy Policy.
'Bad Science' hilariously exposed the tricks that quacks and journalists use to distort science, becoming a 400,000 copy bestseller. Now Ben Goldacre puts the $600bn global pharmaceutical industry under the microscope. What he reveals is a fascinating, terrifying mess. Doctors and patients need good scientific evidence to make informed decisions. But instead, companies run bad trials on their own drugs, which distort and exaggerate the benefits by design. When these trials produce unflattering results, the data is simply buried. All of this is perfectly legal. In fact, even government regulators withhold vitally important data from the people who need it most. Doctors and patient groups have stood by too, and failed to protect us. Instead, they take money and favours, in a world so fractured that medics and nurses are now educated by the drugs industry. The result: patients are harmed in huge numbers. Ben Goldacre is Britain's finest writer on the science behind medicine, and 'Bad Pharma' is the book that finally prompted Parliament to ask why all trial results aren't made publicly available – this edition has been updated with the latest news from the select committee hearings. Let the witty and indefatigable Goldacre show you how medicine went wrong, and what you can do to mend it.
'Bad Science' hilariously exposed the tricks that quacks and journalists use to distort science, becoming a 400,000 copy bestseller. Now Ben Goldacre puts the $600bn global pharmaceutical industry under the microscope. What he reveals is a fascinating, terrifying mess. Doctors and patients need good scientific evidence to make informed decisions. But instead, companies run bad trials on their own drugs, which distort and exaggerate the benefits by design. When these trials produce unflattering results, the data is simply buried. All of this is perfectly legal. In fact, even government regulators withhold vitally important data from the people who need it most. Doctors and patient groups have stood by too, and failed to protect us. Instead, they take money and favours, in a world so fractured that medics and nurses are now educated by the drugs industry. The result: patients are harmed in huge numbers. Ben Goldacre is Britain's finest writer on the science behind medicine, and 'Bad Pharma' is the book that finally prompted Parliament to ask why all trial results aren't made publicly available – this edition has been updated with the latest news from the select committee hearings. Let the witty and indefatigable Goldacre show you how medicine went wrong, and what you can do to mend it.
Due to publisher restrictions the library cannot purchase additional copies of this title, and we apologize if there is a long waiting list. Be sure to check for other copies, because there may be other editions available.
Due to publisher restrictions the library cannot purchase additional copies of this title, and we apologize if there is a long waiting list. Be sure to check for other copies, because there may be other editions available.
About the Author-
Ben Goldacre is a doctor and science writer who wrote the 'Bad Science' column in the Guardian from 2003 to 2011. He has made a number of documentaries for BBC Radio 4, and his first book Bad Science reached Number One in the nonfiction charts, has sold over 500,000 copies. . His second bestselling book, Bad Pharma, was published in 2013.
Reviews-
January 14, 2013 In this searing exposeÌ of the pharmaceutical industry, physician and journalist Goldacre (Bad Science) uncovers a cesspool of corrupt practices designed to sell useless ordangerous drugs to an unsuspecting public. His main focus is the distortion of the science on which evidence-based medicine relies: drug companies, he argues, deploy deliberately biased clinical trials and twisted statistics to exaggerate their drugsâ benefits, while suppressing countless studies that show negative results or deadly side effects. Big Pharmaâs malign influence doesnât stop there, he contends; doctorsâ prescribing practices are determined not by patientsâ needs but by the insidious bribes and blandishments of sales representatives, the industryâs ubiquitous "educational" programs, and fake research articles, journals, and even textbooks signed by independent academics but authored by industry-hired ghost writers. Goldacreâs indictment fingers many culpritsâprofit-hungry industry executives, lax regulatory agencies that collude in hiding crucial information from the public, and complaisant journal editors and university officials who put their imprimatur on blatant misconduct. Drawing on a wealth of research but writing squarely for laypeople, Goldacre conveys complicated scientific, medical, and ethical issues in simple, clear, plainspoken language that pulls no punches. The result is a smart, infuriating diagnosis of the rotten heart of the medical-industrial complex. Agent: ZoeÌ Pagnamenta, the ZoeÌ Pagnamenta Agency.
April 29, 2013 In his latest, British physician and author Goldacre tackles the misdeeds of the pharmaceutical industry. As Goldacre presents a laundry list of flawed research projects, narrator Jonathan Cowley handles the author’s academic style with ease, never missing a beat. His precise annunciation matches the seriousness of the issues at hand, and he successfully balances the shifting tones of the narrative. Yet, as Goldacre recounts his adventures uncovering greed and corruption, Cowley ably takes on the author’s populist persona. Cowley especially entertains in sections devoted to industry schmoozing and networking, providing doses of humor to help bring home the author’s underlying messages. And if technical and scientific sections of the book make for a sometimes-demanding listening experience, Cowley’s winning reading helps broaden the appeal. A Faber & Faber hardcover.
Title Information+
Publisher
HarperCollins Publishers
OverDrive Read
Release date:
EPUB eBook
Release date:
Digital Rights Information+
Copyright Protection (DRM) required by the Publisher may be applied to this title to limit or prohibit printing or copying. File sharing or redistribution is prohibited. Your rights to access this material expire at the end of the lending period. Please see Important Notice about Copyrighted Materials for terms applicable to this content.
Please update to the latest version of the OverDrive app to stream videos.
Device Compatibility Notice
The OverDrive app is required for this format on your current device.
Bahrain, Egypt, Hong Kong, Iraq, Israel, Jordan, Kuwait, Lebanon, Libya, Mauritania, Morocco, Oman, Palestine, Qatar, Saudi Arabia, the Sudan, the Syrian Arab Republic, Tunisia, Turkey, the United Arab Emirates, and Yemen
You've reached your library's checkout limit for digital titles.
To make room for more checkouts, you may be able to return titles from your Checkouts page.
Excessive Checkout Limit Reached.
There have been too many titles checked out and returned by your account within a short period of time.
Try again in several days. If you are still not able to check out titles after 7 days, please contact Support.
You have already checked out this title. To access it, return to your Checkouts page.
This title is not available for your card type. If you think this is an error contact support.
There are no copies of this issue left to borrow. Please try to borrow this title again when a new issue is released.
| Sign In
You will be prompted to sign into your library account on the next page.
If this is your first time selecting “Send to NOOK,” you will then be taken to a Barnes & Noble page to sign into (or create) your NOOK account. You should only have to sign into your NOOK account once to link it to your library account. After this one-time step, periodicals will be automatically sent to your NOOK account when you select "Send to NOOK."
The first time you select “Send to NOOK,” you will be taken to a Barnes & Noble page to sign into (or create) your NOOK account. You should only have to sign into your NOOK account once to link it to your library account. After this one-time step, periodicals will be automatically sent to your NOOK account when you select "Send to NOOK."
You can read periodicals on any NOOK tablet or in the free NOOK reading app for iOS, Android or Windows 8.
